Silver (I)/6-hydroxyiminolumazine compounds differently modify renin-angiotensin system-regulating aminopeptidases A and N in human neuroblastoma and glioma cells.

Ramírez-Expósito MJ, Mayas-Torres MDCarrera-González MP, Jiménez-Pulido SBIllán-Cabeza NA, Sánchez-Sánchez PHueso-Ureña F, Martínez-Martos JMMoreno-Carretero MN.2024-02-262024-02-262014-09Ramírez-Expósito MJ, Mayas-Torres MD, Carrera-González MP, Jiménez-Pulido SB, Illán-Cabeza NA, Sánchez-Sánchez P, Hueso-Ureña F, Martínez-Martos JM, Moreno-Carretero MN. Silver(I)/6-hydroxyiminolumazine compounds differently modify renin-angiotensin system-regulating aminopeptidases A and N in human neuroblastoma and glioma cells. J Inorg Biochem. 2014 Sep;138:56-63.doi: 10.1016/j.jinorgbio.2014.04.019https://hdl.handle.net/10953/2458engAtribución-NoComercial-SinDerivadas 3.0 Españahttp://creativecommons.org/licenses/by-nc-nd/3.0/es/Antitumor activityLumazinePteridineRenin–angiotensin-systemSilverSilver (I)/6-hydroxyiminolumazine compounds differently modify renin-angiotensin system-regulating aminopeptidases A and N in human neuroblastoma and glioma cells.info:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccess